Latest Hospitality News

Charter Hall Long WALE REIT reported a resilient half-year performance with near-full occupancy and solid income growth, reaffirming its FY25 earnings and distribution guidance amid strategic portfolio adjustments.

Charter Hall Long WALE REIT reported solid first-half results for FY25, maintaining strong portfolio occupancy and lease terms while executing significant asset sales and strategic acquisitions. The REIT reaffirmed its full-year earnings and distribution guidance, underscoring confidence in its long-term growth strategy.

SEQ Hospitality Group has formally withdrawn its off-market takeover bid for Eumundi Group following shareholder and court approval of a competing scheme of arrangement. This move effectively ends the takeover offer and confirms the scheme as the path forward for Eumundi shareholders.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

Eumundi Group Limited’s shares have been suspended from ASX trading following Federal Court approval of its acquisition by SEQ Hospitality Group Pty Ltd, marking a pivotal step in the company’s transition.

Eumundi Group's scheme of arrangement has been legally approved, paving the way for SEQ Hospitality Group to acquire all shares at $1.62 each. Trading of Eumundi shares on the ASX is suspended effective immediately, with payment scheduled for mid-February.

The Federal Court of Australia has approved SEQ Hospitality Group’s acquisition of Eumundi Group, setting the stage for a $1.62 per share cash payout to shareholders and imminent suspension of Eumundi’s ASX trading.

Pro Medicus has inked a $53 million, seven-year contract with BayCare to deploy its Visage 7 cloud-based imaging platform across Florida’s largest healthcare system, marking a major step in its North American expansion.

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.